Validations: Lifecycle Re-qualification

Triggers for Re-Qualification: Changes, Trends, and Events

Triggers for Re-Qualification: Changes, Trends, and Events Triggers for Re-Qualification: Changes, Trends, and Events Introduction to Container Closure Integrity and Re-Qualification Container Closure Integrity (CCI) is a critical component in ensuring the safety, efficacy, and quality of pharmaceutical products. It encompasses techniques and methodologies used to verify that drug products are adequately protected against contamination, loss of sterility, or leakage….

Continue Reading Triggers for Re-Qualification: Changes, Trends, and Events

Periodic Review Cadence for CCI: What’s Sensible

Periodic Review Cadence for CCI: What’s Sensible Container Closure Integrity (CCI) testing is critical in ensuring the safety and efficacy of pharmaceutical products. As part of a robust Quality Management System (QMS), CCI must be regularly evaluated to meet regulatory expectations set forth by bodies like the FDA, EMA, and MHRA. This guide provides a comprehensive, step-by-step tutorial for establishing…

Continue Reading Periodic Review Cadence for CCI: What’s Sensible

Re-Qualification Protocols: Efficient Yet Defensible

Re-Qualification Protocols: Efficient Yet Defensible Re-Qualification Protocols: Efficient Yet Defensible Understanding Container Closure Integrity (CCI) The term Container Closure Integrity (CCI) refers to the ability of a container closure system to maintain a sterile barrier against potential environmental contaminants throughout its entire lifecycle. This integrity is crucial in pharmaceutical packaging, especially for parenteral products, as any breach can lead to…

Continue Reading Re-Qualification Protocols: Efficient Yet Defensible

When to Tighten DL or Change Methods

When to Tighten DL or Change Methods Container closure integrity (CCI) is critical in ensuring the sterility and efficacy of pharmaceutical products. Developing and maintaining robust CCI testing methods are crucial for compliance with various regulatory standards, including those from the US FDA, EMA, and MHRA. This tutorial will guide you through the steps to determine when to tighten detection…

Continue Reading When to Tighten DL or Change Methods

Cross-Site Parity and Exceptions for CCI

Cross-Site Parity and Exceptions for CCI The concept of Container Closure Integrity (CCI) is paramount in pharmaceutical manufacturing and quality assurance. Ensuring that the integrity of product containers is maintained throughout their lifecycle, especially across various manufacturing sites, is critical for regulatory compliance and patient safety. This article will provide a comprehensive step-by-step tutorial on how to achieve cross-site parity…

Continue Reading Cross-Site Parity and Exceptions for CCI